title: T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinoma.
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
authors.forename: E H
authors.initials: EH
authors.lastname: Warren
authors.forename: S S
authors.initials: SS
authors.lastname: Tykodi
authors.forename: M
authors.initials: M
authors.lastname: Murata
authors.forename: B M
authors.initials: BM
authors.lastname: Sandmaier
authors.forename: R
authors.initials: R
authors.lastname: Storb
authors.forename: E
authors.initials: E
authors.lastname: Jaffee
authors.forename: R
authors.initials: R
authors.lastname: Childs
authors.forename: J A
authors.initials: JA
authors.lastname: Thompson
authors.forename: P D
authors.initials: PD
authors.lastname: Greenberg
authors.forename: S R
authors.initials: SR
authors.lastname: Riddell
mesh_terms: D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000628:therapy*; D002986:Clinical Trials as Topic; D006086:Graft vs Host Disease; D020350:Graft vs Tumor Effect; D006801:Humans; D007680:Kidney Neoplasms / Q000276:immunology / Q000628:therapy*; D007938:Leukemia / Q000276:immunology / Q000628:therapy*; D015778:Minor Histocompatibility Antigens / Q000737:chemistry* / Q000276:immunology; D009362:Neoplasm Metastasis; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism
chemical_list: D015778:Minor Histocompatibility Antigens